Literature DB >> 15102877

Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I.

Daniel Steinberg1.   

Abstract

This is the first of a series of reviews of the controversy that swirled around the "lipid hypothesis" of atherosclerosis for so many years. Today, in the era of the statins, there is no longer any doubt about the value of decreasing blood cholesterol levels. In fact, "the lower the better" is the position of many clinicians. However, getting to this point has been a long uphill battle marked by heated debate and sometimes violent disagreement. The history of this controversy is worth telling for its own sake and because remembering it may help us avoid similar mistakes in the future. The history of this controversy is worth telling for its own sake and because remembering it may help us avoid similar mistakes in the future. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15102877     DOI: 10.1194/jlr.R400003-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  41 in total

Review 1.  Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?

Authors:  Shah Ebrahim; George Davey Smith
Journal:  Hum Genet       Date:  2007-11-23       Impact factor: 4.132

Review 2.  Predictors of cardiovascular risk in women.

Authors:  Tamer Sallam; Karol E Watson
Journal:  Womens Health (Lond)       Date:  2013-09

Review 3.  A systems biology approach to understanding atherosclerosis.

Authors:  Stephen A Ramsey; Elizabeth S Gold; Alan Aderem
Journal:  EMBO Mol Med       Date:  2010-03       Impact factor: 12.137

4.  PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.

Authors:  Brandon Ason; José W A van der Hoorn; Joyce Chan; Edward Lee; Elsbet J Pieterman; Kathy Khanh Nguyen; Mei Di; Susan Shetterly; Jie Tang; Wen-Chen Yeh; Margrit Schwarz; J Wouter Jukema; Rob Scott; Scott M Wasserman; Hans M G Princen; Simon Jackson
Journal:  J Lipid Res       Date:  2014-09-25       Impact factor: 5.922

Review 5.  The early years of lipoprotein research: from discovery to clinical application.

Authors:  Patty W Siri-Tarino; Ronald M Krauss
Journal:  J Lipid Res       Date:  2016-07-29       Impact factor: 5.922

6.  Lysosomes, cholesterol and atherosclerosis.

Authors:  W Gray Jerome
Journal:  Clin Lipidol       Date:  2010-12-01

Review 7.  Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine.

Authors:  Jianglin Fan; Shuji Kitajima; Teruo Watanabe; Jie Xu; Jifeng Zhang; Enqi Liu; Y Eugene Chen
Journal:  Pharmacol Ther       Date:  2014-09-30       Impact factor: 12.310

8.  Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9.

Authors:  Brandon Ason; Samnang Tep; Harry R Davis; Yiming Xu; Glen Tetzloff; Beverly Galinski; Ferdie Soriano; Natalya Dubinina; Lei Zhu; Alice Stefanni; Kenny K Wong; Marija Tadin-Strapps; Steven R Bartz; Brian Hubbard; Mollie Ranalletta; Alan B Sachs; W Michael Flanagan; Alison Strack; Nelly A Kuklin
Journal:  J Lipid Res       Date:  2011-01-24       Impact factor: 5.922

Review 9.  Obesity, inflammation, and atherosclerosis.

Authors:  Viviane Z Rocha; Peter Libby
Journal:  Nat Rev Cardiol       Date:  2009-04-28       Impact factor: 32.419

Review 10.  Shaggy and calcified aorta: surgical implications.

Authors:  Ikuo Fukuda; Kazuyuki Daitoku; Masahito Minakawa; Wakako Fukuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.